In his “Supreme Court Report” for the July/August 2023 edition of IP Litigator, Partner Ron Kern asks, “What do telegraphic communications, incandescent lamps, wood veering glues, and antibodies have in common?”
The answer is, of course, “nothing.” That was, Kerns writes, until this past May, “when the Supreme Court ruled that Amgen’s antibody claims, like Morse’s telegraphic communication claims, Sawyer and Man’s incandescent lamp claims, and Perkins’ wood veneering glue claims, were invalid for lacking enablement.” Kern’s article goes on to explore the ruling and its ramifications.